METRONIDAZOLE INJECTION, USP 5 MG
METRONIDAZOLE : 5 MG · DIN 00870420 · BAXTER CORPORATION
Health Canada status: MARKETED
What is METRONIDAZOLE INJECTION, USP?
METRONIDAZOLE INJECTION, USP 5 MG contains METRONIDAZOLE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 00870420, held by BAXTER CORPORATION, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 03-Sep-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is METRONIDAZOLE INJECTION, USP used for?
METRONIDAZOLE INJECTION, USP is indicated for: • Treatment of bacterial infections of serious anaerobic intra-abdominal infections due to susceptible anaerobic bacteria, such as Bacteroides fragilis (and other species of Bacteroides), Clostridium, Fusobacterium, Peptococcus, and Peptostreptococcus species. • Prevention of bacterial infections of the incidence of post-operative infections in patients undergoing elective colorectal surgery.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00870420 |
|---|---|
| Brand name | METRONIDAZOLE INJECTION, USP |
| Generic / active ingredient | METRONIDAZOLE : 5 MG |
| Manufacturer | BAXTER CORPORATION |
| Strength | 5 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | J01XD01 METRONIDAZOLE |
| AHFS class | 08:30.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 03-Sep-2019 |
| Original market date | 1990-12-31 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Boxes of 48.
Is METRONIDAZOLE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Discontinued — reported by PFIZER CANADA ULC, last seen 19 May 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code J01XD01 METRONIDAZOLE. 2 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PMS-METRONIDAZOLE | 500 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 00783137 |
| FLORAZOLE ER | 750 MG | TABLET (EXTENDED-RELEASE) | FERRING INC | CANCELLED POST MARKET | DIN 02244405 |
| METRONIDAZOLE INJECTION USP | Strength | Solution | PFIZER CANADA ULC 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5 | CANCELLED POST MARKET | DIN 00649074 |
| METRONIDAZOLE TAB 250MG | 250 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00420409 |
| NOVO-NIDAZOL TAB 250MG | 250 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021555 |
| PMS-METRONIDAZOLE 250MG/TAB | 250 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00584339 |
Who else supplies METRONIDAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METRONIDAZOLE appears in 2910 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.